Publications by authors named "Maike Wientjes"

Claim this Profile
C
Cost-effectiveness of nurse-led home monitoring of serum urate for gout patients starting with urate-lowering therapy in secondary care: a modeling study.
Jeffrey van der Ven, Marcel Flendrie, Fenne van Dijck, Maike H M Wientjes, Noortje van Herwaarden

Semin Arthritis Rheum· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cohort Study on Drug Survival and Tolerability of Adalimumab Biosimilar Transitioning: Pharmaceutical Properties Do Matter.
Amy C D Peeters, Maike H M Wientjes, Wieland D Müskens, David F Ten Cate, Laura C Coates

Clin Pharmacol Ther· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adalimumab serum concentration to choose a subsequent biological DMARD in patients with rheumatoid arthritis (ADDORA-switch): results of a blinded randomised test-treatment trial.
Maike H M Wientjes, Sadaf Atiqi, Gerrit J Wolbink, Michael T Nurmohamed, Maarten Boers

Ann Rheum Dis· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Ischaemic cardiovascular risk with allopurinol and protective effect of colchicine in gout: a Dutch nationwide pharmaco-epidemiological study.
Iris Rose Peeters, Maike H M Wientjes, Isla S Mackenzie, Merel A A Opdam, Marcel Flendrie

Eur J Prev Cardiol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dose reduction of rituximab in clinical practice: a retrospective cohort study of rheumatoid arthritis patients in low disease activity on rituximab.
Maike H M Wientjes, Jordy van Huissteden, Noortje van Herwaarden, Lise M Verhoef, Alfons A den Broeder

Clin Exp Rheumatol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapy with JAK inhibitors or bDMARDs and the risk of cardiovascular events in the Dutch rheumatoid arthritis population.
Calin D Popa, Merel A A Opdam, Nathan den Broeder, Hanne van Ballegooijen, Kelly Mulder, Maike H M Wientjes

Rheumatology (Oxford)· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The added value of predictive biomarkers in treat-to-target strategies for rheumatoid arthritis patients: a conceptual modelling study.
Maike H M Wientjes, Evy Ulijn, Wietske Kievit, Robert B M Landewé, Inger Meek

Rheumatology (Oxford)· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Methotrexate to prevent progression to rheumatoid arthritis?].
Alfons A den Broeder, Noortje van Herwaarden, Maike H M Wientjes

Ned Tijdschr Geneeskd· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prediction of response to anti-TNF treatment using laboratory biomarkers in patients with rheumatoid arthritis: a systematic review.
Maike H M Wientjes, Alfons A den Broeder, Paco M J Welsing, Lise M Verhoef, Bart J F van den Bemt

RMD Open· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug levels, anti-drug antibodies and B-cell counts were not predictive of response in rheumatoid arthritis patients on (ultra-)low-dose rituximab.
Maike H M Wientjes, Titia M G Gijzen, Nathan den Broeder, Karien Bloem, Annick de Vries

Rheumatology (Oxford)· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Using adalimumab serum concentration to choose a subsequent biological DMARD in rheumatoid arthritis patients failing adalimumab treatment (ADDORA-switch): study protocol for a fully blinded randomised superiority test-treatment trial.
Maike H M Wientjes, Sadaf Atiqi, Gerrit Jan Wolbink, Michael T Nurmohamed, Maarten Boers

Trials· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk factors for in-hospital mortality in laboratory-confirmed COVID-19 patients in the Netherlands: A competing risk survival analysis.
Gerine Nijman, Maike Wientjes, Jordache Ramjith, Nico Janssen, Jacobien Hoogerwerf

PLoS One· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic drug monitoring of adalimumab in RA: no predictive value of adalimumab serum levels and anti-adalimumab antibodies for prediction of response to the next bDMARD.
Evy Ulijn, Nathan den Broeder, Maike Wientjes, Noortje van Herwaarden, Inger Meek

Ann Rheum Dis· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Out-of-pocket payments and catastrophic household expenditure to access essential surgery in Malawi - A cross-sectional patient survey.
Leon Bijlmakers, Maike Wientjes, Gerald Mwapasa, Dennis Cornelissen, Eric Borgstein

Ann Med Surg (Lond)· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical utility of therapeutic drug monitoring in biological disease modifying anti-rheumatic drug treatment of rheumatic disorders: a systematic narrative review.
Noortje Van Herwaarden, Bart J F Van Den Bemt, Maike H M Wientjes, Cornelis Kramers, Alfons A Den Broeder

Expert Opin Drug Metab Toxicol· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis